Chargement en cours...

Structure Based Development of Phenyl-imidazole-derived Inhibitors of Indoleamine 2,3-Dioxygenase

Indoleamine 2,3-dioxygenase (IDO) is emerging as an important new therapeutic target for the treatment of cancer, chronic viral infections, and other diseases characterized by pathological immune suppression. With the goal of developing more potent IDO inhibitors, a systematic study of 4-phenyl-imid...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Kumar, Sanjeev, Jaller, Daniel, Patel, Bhumika, LaLonde, Judith M., DuHadaway, James B., Malachowski, William P., Prendergast, George C., Muller, Alexander J.
Format: Artigo
Langue:Inglês
Publié: 2008
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3159384/
https://ncbi.nlm.nih.gov/pubmed/18665584
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/jm800512z
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!